Skip to main content
Premium Trial:

Request an Annual Quote

Multiplicom, ICM, ICAN Partner on MDx Development

NEW YORK (GenomeWeb News) – Belgian molecular diagnostic company Multiplicom today announced a deal with French institutes ICM and ICAN to develop molecular diagnostic tests for the identification of genetic mutations associated with cardiovascular, metabolic, and neurological diseases.

Multiplicom will pair its expertise on MDx test development using massive parallel sequencing with ICM and ICAN's disease knowledge and well-documented samples to develop and validate the tests. Multiplicom will commercialize any products resulting from the partnership, which as a first project is developing a test for the early onset of diabetes. Additional projects will follow, the company said.

Based in Antwerp, Belgium, Multiplicom designs, develops, and commercializes MDx tests based on massively parallel sequencing. Last year, it raised about $3 million. ICM and ICAN are hospital-university institutes at Hôpital Pitié Salpêtrière in Paris.

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.